Brief: Delcath Systems Announces Update To National Comprehensive Cancer Network Clinical Practice Guidelines
14/02/2025 13:39
Feb 14 (Reuters) - Delcath Systems DCTH.O :
* DELCATH SYSTEMS ANNOUNCES UPDATE TO NATIONAL COMPREHENSIVE
CANCER NETWORK CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT OF
METASTATIC UVEAL MELANOMA
* DELCATH SYSTEMS: UPDATED NCCN GUIDELINES INCLUDE HEPZATO
KIT AS
CATEGORY 2A TREATMENT FOR PATIENTS WITH HEPATIC-DOMINANT UVEAL
MELANOMA
Source text: ID:nBw4Rt5FZa
Further company coverage: DCTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Delcath Systems
See all newsBrief: Delcath Systems Highlights Clinical Program Presentations At Esmo Congress 2026 And Independent Data On Percutaneous Hepatic Perfusion In Liver-Dominant Metastatic Uveal Melanoma
Brief: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule
Delcath Systems Inc reports results for the quarter ended June 30 - Earnings Summary
Delcath Systems Q2 revenue rises, beats estimates
Delcath Systems Inc expected to post a loss of 9 cents a share - Earnings Preview